Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
At Commodity Classic in San Antonio, growers explore new herbicide options, John Deere’s latest 8 Series tractors, and cutting-edge ag technology shaping the 2026 planting season. Here are some of RFD NEWS’ highlights from the event so far.
Farm Bureau economist Danny Munch explains the importance of timely enrollment, and how the program helps dairy producers safeguard their operations against volatile milk markets.
The Ranger Road Fire is fully contained after burning nearly 300,000 acres. Ranchers face significant cattle and fence losses, with recovery efforts underway.
East Tennessee Children’s Hospital officially becomes Dolly Parton Children’s Hospital, marking a new era of compassionate, world-class pediatric care in Tennessee.
Delays on year-round E15 keep potential corn demand and fuel savings in limbo.
Analysts warn the closed U.S.-Mexico border is straining cattle supplies and packing capacity. StoneX and USDA data point to long-term industry shifts.
